Clinical trial Recruiting at 1 site Observational Ages 18 and up

TUVA BX and iCover stent grafts used in BEVAR for complex aortic aneurysms

Official title: Retrospective Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)

Run by JOTEC GmbH · NCT07540507 · Data updated 2026-11-12

This study looks at whether the TUVA BX and iCover stent grafts used during BEVAR procedures are safe and perform well in real-world patients with complex abdominal or thoracoabdominal aneurysms.

More Abdominal Aortic Aneurysm trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment105 (estimated)
SponsorJOTEC GmbH
Industry-sponsored
Locations1 site (Heerlen)
StatusRecruiting
StartedApril 14, 2026
Main results expectedSeptember 30, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 6, 2026
Trial IDNCT07540507 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) who had a completed BEVAR repair for TAAA or complex AAA with TUVA BX or iCover bridging and at least one target vessel connected, and who have completed or will complete 1-year follow-up.

Probably not a fit

Patients who had ruptured aneurysms, hemodynamic instability at procedure, or those enrolled in conflicting investigational studies may not derive benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective, multicenter observational registry evaluating TUVA BX and iCover stent grafts implanted during BEVAR for complex aortic aneurysms. Researchers will collect existing medical records from the index procedure through a 1-year follow-up to assess safety and effectiveness in routine practice. No comparison group is included, and no new treatments or visits are planned beyond standard care. About 105 patients across up to 25 hospitals in Europe, the UK, and Switzerland are expected to participate, with final results anticipated in December 2026.

Why it matters

Potential benefit: If successful, findings could support broader use of TUVA BX and iCover grafts in BEVAR by demonstrating real-world safety and performance.

How similar studies have gone: Previous Registries and observational assessments have provided useful safety and performance data for endovascular devices in similar settings, informing this study’s approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years at the time of index procedure
* Patients must have a completed treatment of TAAA or complex AAA treated with E-nside TAAA Multibranch Stent Graft System (E-nside) or E-xtra Design MultiBranch Stent Graft System (EDM) and with at least one target vessel (CT, SMA, LRA, RRA) bridged with any combination of TUVA BX or iCover.
* The index procedure was performed after January 2020.
* The patient is not deceased and has already completed or expects to complete the 1 year follow-up visit prior to July 2026; or the patient died.
* Patients have been consented according to the local regulation.

Exclusion Criteria:

* Patient treated for ruptured aneurysm or who were otherwise hemodynamically unstable before the procedure.
* Patients enrolled in an investigational study that could confound registry endpoints at index procedure.
* Patients who developed a new onset of aortic disease (in any segment) since index procedure, potentially having an impact on the performance of the TAAA or TUVA BX /iCover, devices at the discretion of the investigator

Where it's running

  • Zuyderland Medisch Centrum
    Heerlen, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.